This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Counsel for the federal government described the tranquilizers librium and valium as having a potential for abuse, while an attorney for the manufacturer said they are safe, effective drugs and rarely abused.The statements were made at a Food and Drug Administration hearing in which the manufacturer, Hoffmann-LaRoche, Inc., Nutley, NJ, is opposing a proposal to place the two tranquilizers under the drug abuse control amendment. The amendment covers barbiturates, amphetamines, and some other drugs having a potential for abuse.Separate hearings have been held on meprobamate. At one session, Dr. Samuel Kaim, the chief of research in psychiatry and neurology for the Veterans Administration, testified that records of 65,000 patients discharged from seven VA hospitals during 1965 showed only one or two had taken excessive amounts of the tranquilizer meprobamate. He said that the entire VA hospital system had 629,000 patients discharged during 1965, and 3,481 had drug-related
WASHINGTON NEWS. JAMA. 1966;197(8):19–21. doi:10.1001/jama.1966.03110080011003
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.